Characterization of PIVKA ‐ II Molecular Forms via Size Exclusion Chromatography and Hydrophobic Interaction Chromatography in HCC Patients

Documenti analoghi

• Clinical value of serumAFPandPIVKA‐IIfor diagnosis, treatment and prognosis of hepatocellular carcinoma
  di: Yujiao Jin, et al.
  Pubblicazione: (2024)
• Effects of Blood Collection Tubes on the Quantification of Catecholamines and Their O‐Methylated Metabolites by Liquid Chromatography Coupled With Tandem Mass Spectrometry
  di: Rong Su, et al.
  Pubblicazione: (2024)
• Ultra‐Sensitive Quantification of Indoxyl Sulfate and 3‐Carboxy‐4‐Methyl‐5‐Propyl‐2‐Furanpropanoic Acid in Plasma Using Ultra‐Performance Liquid Chromatography Coupled to Quadrupole Time‐of‐Flight Mass Spectrometry
  di: Jun Negami, et al.
  Pubblicazione: (2025)
• A Rapid Colorimetric Method for Determining Calcium, Inorganic Phosphorus, and Zinc in Human Milk Using Clinical Laboratory Reagents
  di: Miori Tanaka, et al.
  Pubblicazione: (2025)
• Characterization of COVID‐19‐Associated Candidemia Among Burn Patients
  di: Maryam Salimi, et al.
  Pubblicazione: (2025)